Theseus Pharmaceuticals Inc (THRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | THRX | AMGN | BMY | GILD | VRTX |
| Company | Theseus Pharmaceuticals Inc | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 4.06 | 263.11 | 57.25 | 92.62 | 391.87 |
| High | 4.07 | 264.80 | 57.64 | 93.22 | 402.69 |
| Low | 4.06 | 260.87 | 56.80 | 91.79 | 390.92 |
| Last | 4.06 | 263.44 | 57.38 | 93.08 | 401.55 |
| Change | unch | +0.06 | +0.05 | +0.51 | +4.28 |
| % Change | unch | +0.02% | +0.09% | +0.55% | +1.08% |
| Volume | 3,123,100 | 1,399,892 | 4,056,077 | 2,164,968 | 1,148,187 |
| 20-Day Average Volume | 578,445 | 5,076,171 | 11,636,732 | 7,469,282 | 1,813,128 |
| Previous Close | 4.06 | 263.38 | 57.33 | 92.57 | 397.27 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 4.04 | 273.44 | 57.90 | 92.11 | 454.51 |
| 20-Day Raw Stochastic | 61.54% | 22.11% | 39.98% | 70.00% | 24.35% |
| 20-Day Relative Strength | 60.97% | 32.10% | 52.46% | 56.07% | 31.32% |
| Weighted Alpha | -14.40 | -15.25 | +19.17 | +24.33 | -9.84 |
| Today's Opinion | 40% Buy | 88% Sell | 80% Buy | 100% Buy | 72% Sell |
| Previous Opinion | 40% Buy | 88% Sell | 80% Buy | 100% Buy | 72% Sell |
| Last Month's Opinion | 8% Buy | 40% Sell | 100% Buy | 80% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.49% since 02/06/24 | -1.30% since 12/16/24 | +2.55% since 12/16/24 | +1.03% since 12/16/24 | -14.15% since 12/16/24 |
| Low | 4.06 on 02/13/24 | 253.30 on 12/19/24 | 56.05 on 12/17/24 | 90.27 on 12/19/24 | 377.85 on 12/19/24 |
| High | 4.11 on 02/07/24 | 270.26 on 12/17/24 | 58.54 on 12/18/24 | 93.59 on 12/17/24 | 474.18 on 12/17/24 |
| 1-Month | |||||
| %Chg | +0.74% since 01/12/24 | -10.69% since 11/22/24 | -2.68% since 11/22/24 | +3.12% since 11/22/24 | -10.89% since 11/22/24 |
| Low | 3.98 on 01/22/24 | 253.30 on 12/19/24 | 55.04 on 12/13/24 | 89.15 on 12/13/24 | 377.85 on 12/19/24 |
| High | 4.11 on 02/07/24 | 297.32 on 11/25/24 | 60.68 on 11/25/24 | 94.65 on 12/11/24 | 476.46 on 12/10/24 |
| 3-Month | |||||
| %Chg | +89.72% since 11/13/23 | -21.62% since 09/23/24 | +14.57% since 09/23/24 | +10.73% since 09/23/24 | -12.64% since 09/23/24 |
| Low | 2.92 on 11/14/23 | 253.30 on 12/19/24 | 49.11 on 09/25/24 | 81.83 on 09/26/24 | 377.85 on 12/19/24 |
| High | 4.20 on 12/27/23 | 335.41 on 09/24/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| 6-Month | |||||
| %Chg | +30.13% since 08/11/23 | -14.64% since 06/21/24 | +36.64% since 06/21/24 | +31.60% since 06/21/24 | -14.26% since 06/21/24 |
| Low | 2.05 on 11/13/23 | 253.30 on 12/19/24 | 39.35 on 07/05/24 | 66.01 on 07/05/24 | 377.85 on 12/19/24 |
| High | 4.20 on 12/27/23 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 179,574 | 141,575,456 | 116,275,392 | 115,366,840 | 102,308,544 |
| Shares Outstanding, K | 44,230 | 537,533 | 2,028,177 | 1,246,266 | 257,529 |
| Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -50,610,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 11,892,000,000 | 7,545,000,000 | 2,771,900,000 |
| Last Quarter Net Income | -13,500,000 | 2,830,000,000 | 1,211,000,000 | 1,253,000,000 | 1,045,400,000 |
| 60-Month Beta | 3.98 | 0.55 | 0.45 | 0.18 | 0.36 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.31 on 11/17/23 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 | 4.38 on 11/04/24 |
| Latest Earnings Date | 03/14/24 | 02/04/25 | 02/06/25 | 02/11/25 | 02/03/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | 0.770 on 12/13/24 | N/A |
| Next Ex-Dividends Date | 09/08/15 | 02/14/25 | 01/03/25 | 12/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.70 | 49.00 | 20.90 | 0.00 |